← 產業報告目錄
Nicotinamide Adenine Dinucleotide Market Size, Share & Trends Analysis Report By Grade (Food, Pharmaceutical, And Others), By Application (Dietary Supplements, Pharmaceuticals, Anti-Aging Products And Others), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Other出版日期 2026-01-03頁數 180報告編號 INSIGHTACE-06e042024e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Nicotinamide Adenine Dinucleotide Market is projected to progress at a compound annual growth rate of 13.02% throughout the 2025–2034 forecast period.
Nicotinamide Adenine Dinucleotide covers The crucial pyridine nucleotide nicotinamide adenine dinucleotide (NAD+) is required for several critical cellular processes, including DNA repair, epigenetically regulated gene expression, intracellu. Rapid advancements and evolving end-user preferences are reshaping how industrial entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the industrial sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nicotinamide Adenine Dinucleotide Market Snapshot
Chapter 4. Global Nicotinamide Adenine Dinucleotide Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Grade Type Estimates & Trend Analysis
5.1. by Grade Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Grade Type:
5.2.1. Food Grade
5.2.2. Pharmaceutical Grade
5.2.3. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Dietary Supplements
6.2.2. Pharmaceuticals
6.2.3. Anti-aging Products
6.2.4. Others
Chapter 7. Nicotinamide Adenine Dinucleotide Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Nicotinamide Adenine Dinucleotide Market Revenue (US$ Million) Estimates and Forecasts by Grade Type, 2021-2034
7.1.2. North America Nicotinamide Adenine Dinucleotide Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.1.3. North America Nicotinamide Adenine Dinucleotide Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.2.2. Europe Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.2.3. Europe Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.3.2. Asia Pacific Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.3.3. Asia Pacific Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.4.2. Latin America Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.4.3. Latin America Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Grade Type, 2021-2034
7.5.2. Middle East & Africa Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by Application, 2021-2034
7.5.3. Middle East & Africa Nicotinamide Adenine Dinucleotide Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Bontac Bioengineering
8.2.2. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
8.2.3. F. Hoffmann-La Roche Ltd
8.2.4. HiMedia Laboratories
8.2.5. NutriScience Innovations, LLC
8.2.6. Nutrifoods
8.2.7. Bontac Bio-engineering(shenzhen)co., ltd
8.2.8. Krackeler Scientific
8.2.9. Shandong Lankang Bio-Technology Co., Ltd.
8.2.10. OYC Americas, Inc.
8.2.11. Xi'an Yinherb Bio-Tech Co., Ltd
8.2.12. Shenzhen Hygieia Biotechnology Co., Ltd
8.2.13. Zhejiang Dazhan Biotechnology Co., Ltd.
8.2.14. Otto Chemie Pvt. Ltd.
8.2.15. Uthever
8.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們